C07C211/07

STABLE ALKALI AMIDE SOLUTIONS AND PROCESSES FOR PREPARING SAME

The object of the invention are solutions of alkali metal amides MNR.sup.1R.sup.2, wherein M is an alkali metal selected from Li, Na, K, Rb, Cs; R.sup.1 and R.sup.2 independently of one another are linear, branched or cyclic alkyl groups having 1 to 8 C atoms or together are a cycloalkyl radical, the alkali metal amides being present in methyltetrahydropyran or in a solvent mixture containing methyltetrahydropyran, and processes for their preparation.

STABLE ALKALI AMIDE SOLUTIONS AND PROCESSES FOR PREPARING SAME

The object of the invention are solutions of alkali metal amides MNR.sup.1R.sup.2, wherein M is an alkali metal selected from Li, Na, K, Rb, Cs; R.sup.1 and R.sup.2 independently of one another are linear, branched or cyclic alkyl groups having 1 to 8 C atoms or together are a cycloalkyl radical, the alkali metal amides being present in methyltetrahydropyran or in a solvent mixture containing methyltetrahydropyran, and processes for their preparation.

GINKGOLIDE B DERIVATIVE AND SALT THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF

The present invention relates to the technical field of medicine, and to derivatives represented by formula 1 and formula 2 in which a carboxylic acid group is introduced into the structure of Ginkgolide B by means of a hydroxyl group at the 10-position and ester derivatives of carboxylic acid groups, and pharmaceutically acceptable organic or inorganic salts. Ginkgolide B is used as a parent body and is prepared by means of chemical structure modification so as to achieve the goals of improving solubility, increasing bioavailability and enhancing healing efficacy. The prepared compound and carboxylate salts thereof have significant platelet activating factor antagonism, an anticoagulant effect and an anti-acute cerebral ischemia effect, and can be used for preparing a drug for preventing and treating ischemic stroke, thrombosis, angina pectoris, cardiopulmonary infarction, as well as inflammation, asthma and other diseases related to a platelet activating factor.

##STR00001##

METHOD FOR SYNTHESIS OF ORGANIC IODIDES, A PEROVSKITE-FORMING COMPOSITION COMPRISING AN ORGANIC IODIDE AND A PHOTOVOLTAIC CELL WITH A PEROVSKITE LAYER OBTAINED THEREFROM

A method for obtaining a salt with a general formula: R.sub.xNI, wherein: R.sub.xN is an organic cation (R.sub.xN.sup.+), R represents substituents (R−) independently selected from a group consisting of organic substituents: R.sup.1−, R.sup.2—, R.sup.3— and hydrogen (H—), x is a number of the substituents R— directly linked with the nitrogen (N) atom in the organic cation R.sub.xN.sup.+, wherein x is 3 or 4, I is an iodide anion (I.sup.−). The method comprises: preparing a reaction mixture comprising the steps of: synthesizing hydrogen iodide (HI) in situ by mixing molecular iodine (I.sub.2) with formic acid (COOH) in a molar ratio of molecular iodine (I.sub.2): formic acid (COOH) of no less than 1.01:1, in a solvent medium, introducing into the solvent medium a compound being a donor of organic cation R.sub.xN.sup.+ in an amount providing the molar ratio of the donor of organic cation R.sub.xN.sup.+: molecular iodine (I.sub.2) of no less than 1.01:1, and maintaining the reaction mixture at a temperature of not less than 20° C. for the time necessary to obtain the reaction product being the salt with the general formula R.sub.xNI. The obtained product is a substrate for synthesis of perovskites.

METHOD FOR SYNTHESIS OF ORGANIC IODIDES, A PEROVSKITE-FORMING COMPOSITION COMPRISING AN ORGANIC IODIDE AND A PHOTOVOLTAIC CELL WITH A PEROVSKITE LAYER OBTAINED THEREFROM

A method for obtaining a salt with a general formula: R.sub.xNI, wherein: R.sub.xN is an organic cation (R.sub.xN.sup.+), R represents substituents (R−) independently selected from a group consisting of organic substituents: R.sup.1−, R.sup.2—, R.sup.3— and hydrogen (H—), x is a number of the substituents R— directly linked with the nitrogen (N) atom in the organic cation R.sub.xN.sup.+, wherein x is 3 or 4, I is an iodide anion (I.sup.−). The method comprises: preparing a reaction mixture comprising the steps of: synthesizing hydrogen iodide (HI) in situ by mixing molecular iodine (I.sub.2) with formic acid (COOH) in a molar ratio of molecular iodine (I.sub.2): formic acid (COOH) of no less than 1.01:1, in a solvent medium, introducing into the solvent medium a compound being a donor of organic cation R.sub.xN.sup.+ in an amount providing the molar ratio of the donor of organic cation R.sub.xN.sup.+: molecular iodine (I.sub.2) of no less than 1.01:1, and maintaining the reaction mixture at a temperature of not less than 20° C. for the time necessary to obtain the reaction product being the salt with the general formula R.sub.xNI. The obtained product is a substrate for synthesis of perovskites.

Method for efficiently synthesizing primary amines

Disclosed is a method for efficiently synthesizing primary amines, which comprises using carbonyl compounds or alcohol compounds as reaction substrate, liquid ammonia or alcohol solutions of ammonia as nitrogen source, and hydrogen as hydrogen source, and reacting in reaction medium catalyzed by a cobalt-based catalyst to obtain the primary amines. Due to high catalytic activity, the method can realize the reductive amination of carbonyl compounds and the hydrogen-borrowing amination of alcohol compounds at low temperatures in a short time to obtain the primary amines with high yield, and is applicable to a wide range of substrates. The obtained primary amines can be used as raw materials with high extra value for producing polymers, medicines, dyes and surfactants. Further, the cobalt-based catalyst has a good industrial application prospect because it is magnetic which can facilitate separation and recycling of the catalyst. Moreover, the inexpensive cobalt-based catalyst can significantly reduce industrialization cost.

Method for efficiently synthesizing primary amines

Disclosed is a method for efficiently synthesizing primary amines, which comprises using carbonyl compounds or alcohol compounds as reaction substrate, liquid ammonia or alcohol solutions of ammonia as nitrogen source, and hydrogen as hydrogen source, and reacting in reaction medium catalyzed by a cobalt-based catalyst to obtain the primary amines. Due to high catalytic activity, the method can realize the reductive amination of carbonyl compounds and the hydrogen-borrowing amination of alcohol compounds at low temperatures in a short time to obtain the primary amines with high yield, and is applicable to a wide range of substrates. The obtained primary amines can be used as raw materials with high extra value for producing polymers, medicines, dyes and surfactants. Further, the cobalt-based catalyst has a good industrial application prospect because it is magnetic which can facilitate separation and recycling of the catalyst. Moreover, the inexpensive cobalt-based catalyst can significantly reduce industrialization cost.

SELECTIVE TERMINAL FUNCTIONALIZATION OF ALKANES

The present invention provides a method for selectively functionalizing alkanes through a sequential biocatalytic dehydrogenation followed by isomerization-hydrofunctionalization reaction.

SELECTIVE TERMINAL FUNCTIONALIZATION OF ALKANES

The present invention provides a method for selectively functionalizing alkanes through a sequential biocatalytic dehydrogenation followed by isomerization-hydrofunctionalization reaction.

CO-CRYSTAL OR SALT
20230279032 · 2023-09-07 ·

The invention relates to a co-crystal or salt comprising psilocybin and a co-former. The co-crystal or salt is useful in methods of treating or preventing a disease or condition selected from depression, anxiety, death anxiety, demoralization, adjustment disorders, hopelessness, suicidal ideation, desire for hastened death, cocaine-related disorders, opioid-related disorders and stimulant-related disorders in a patient. A kit comprising the co-crystal or salt is also described.